← Back to Clinical Trials
Recruiting NCT05223790

Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.

Trial Parameters

Condition Neonatal
Sponsor University Hospital, Lille
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 0 Days
Max Age 7 Days
Start Date 2022-03-22
Completion 2025-03
Interventions
Pain measurement during care procedures in neonatal reanimation

Brief Summary

The Newborn Infant Parasympathetic Evaluation (NIPE) was developed as a method of analysis of the heart rate variability. The monitor gives a value between 0 (low value of the parasympathetic component) and 100 (high value of the parasympathetic component). So far, the measure of the heart failure variability by using the NIPE in infant born very premature ventilated and sedated in neonatal reanimation has not been realised and validated as an evaluation method of the pain and discomfort related to neonatal care.

Eligibility Criteria

Inclusion Criteria: * Infant born very premature before 34 weeks of amenorrhoea + 0 day * Age ≤ 7 days * Admitted in neonatal reanimation * Sedated, intubated, ventilated Exclusion Criteria: * High frequency oscillation ventilation * Heart rate non sinusal * Inotropes and atropine * Opposition from the guardian of parental authority * Difficulty of comprehension or communication making the parental information impossible

Related Trials